Activity-dependent neuronal plasticity is a fundamental mechanism through which the nervous system adapts to sensory experience. Several lines of evidence suggest that parvalbumin (PV+) interneurons are essential in this process, but the molecular mechanisms underlying the influence of experience on interneuron plasticity remain poorly understood. Perineuronal nets (PNNs) enwrapping PV+ cells are long-standing candidates for playing such a role, yet their precise contribution has remained elusive. We show that the PNN protein Brevican is a critical regulator of interneuron plasticity. We find that Brevican simultaneously controls cellular and synaptic forms of plasticity in PV+ cells by regulating the localization of potassium channels and AMPA receptors, respectively. By modulating Brevican levels, experience introduces precise molecular and cellular modifications in PV+ cells that are required for learning and memory. These findings uncover a molecular program through which a PNN protein facilitates appropriate behavioral responses to experience by dynamically gating PV+ interneuron function.
Correspondence beatriz.rico@kcl.ac.uk In Brief Favuzzi et al. unravel an activityregulated cell-specific molecular program in PV+ interneurons. By simultaneously regulating the excitatory inputs and firing properties of PV+ cells, a perineuronal net protein drives PV+ interneuron wiring as well as network adaptation to experience.
INTRODUCTION
Experience-dependent plasticity endows neural circuits in the cerebral cortex with the flexibility required for adapting to a continuously changing environment, thereby contributing to sensory perception, cognition, and behavior. The maintenance of precise neuronal coding during fluctuations in activity requires the balanced interaction between excitation and inhibition (Froemke, 2015; Hensch et al., 1998) , a process that is dynamically sustained by the function of cortical parvalbumin-expressing (PV+) interneurons (Xue et al., 2014) . Although several lines of evidence emphasize pivotal roles for PV+ cells in controlling the gain of sensory-related responses and learning (Wilson et al., 2012; Yazaki-Sugiyama et al., 2009) , the molecular and cellular mechanisms by which PV+ interneurons influence these processes are poorly understood.
PV+ cells can adapt their intrinsic properties (cellular plasticity) and outputs (synaptic plasticity) in response to sensory experience. These cells display a remarkable dynamism that allows them to exist in different ''cell states'' or configurations, depending on the behavioral context (Dehorter et al., 2015; Donato et al., 2013; Lagler et al., 2016) . While the functional relevance of this novel form of experience-dependent plasticity during behavior is clear (Donato et al., 2013) , the molecular mechanisms regulating the adaptability of PV+ interneurons to changing levels of neuronal activity are largely unknown. The lack of information about these processes is particularly striking because PV+ cell dysfunction has been linked to impaired cognition in psychiatric disorders (Cardin et al., 2009; Hu et al., 2014; Sohal et al., 2009) . Hence, the identification of the relevant molecular mediators of this form of plasticity may offer novel therapeutic strategies to recover from deficits in perception, learning, and memory associated with a repertoire of diseases.
The induction and expression of neural plasticity-cellular and synaptic-relies on complex interactions between neurons and their extracellular environment. The extracellular matrix contains potential candidates for modulating neuronal responses to activity changes. For instance, most cortical PV+ interneurons are wrapped by a specialization of the extracellular matrix known as perineuronal nets (PNNs), which includes chondroitin sulfate proteoglycans (CSPGs) (Deepa et al., 2006) . The maturation of PNNs around PV+ cells coincides with the closure of the critical period, a window of enhanced plasticity across different brain regions during early postnatal life (Takesian and Hensch, 2013) . It has been suggested that PNNs contribute to this process by promoting synapse stabilization and limiting synaptic rearrangements beyond the critical period for plasticity (Pizzorusso et al., 2002) . Consistently, pharmacological degradation of CSPGs in the adult reactivates cortical plasticity and enhances learning (Gogolla et al., 2009) . However, in spite of the unequivocal role of PNNs in the regulation of cortical plasticity, the precise mechanism through which PNNs mediate this process remains a mystery.
Brevican (BCAN) is one of the most abundant CSPGs in the brain and a fundamental component of the PNNs (Frischknecht et al., 2014) . It is expressed in several brain regions from early postnatal development, mostly inside glial cells and around neurons (Seidenbecher et al., 2002) . Though its function is currently unclear, three lines of evidence suggest that BCAN may play a key role regulating experience-dependent plasticity in cortical circuits: (1) BCAN is a component of PNNs surrounding PV+ cells (Valenzuela et al., 2014) ; (2) BCAN is present in cell membranes and synaptosomal fractions (Seidenbecher et al., 2002) ; and (3) BCAN is required for long-term potentiation (LTP) in the hippocampus (Brakebusch et al., 2002) .
Here we identify the molecular mechanism through which the PNN protein BCAN influences cellular and synaptic plasticity in response to changes in the environment. We demonstrate that BCAN shapes the intrinsic properties of PV+ interneurons and sculpts their synaptic inputs by controlling the localization of potassium channels and the levels of synaptic AMPA receptors, respectively. Moreover, in contrast to the long-standing view that PNN proteins are static and function just as a break for synaptic plasticity (Nabel and Morishita, 2013; Takesian and Hensch, 2013) , we show that BCAN is dynamically regulated by activity and that its function is fundamentally required for spatial working and short-term memories. These results therefore reveal that BCAN plays a key role in gating the function of PV+ interneurons, thereby enabling coordinated circuit responses to experience. Our findings clarify the molecular and cellular events underlying the function of PNN proteins in neuronal plasticity.
RESULTS

Brevican Is Expressed in PV+ Interneurons and Has a Synaptic Localization
Brevican protein (BCAN) has been found in several brain regions and its expression is described as a diffuse, dense net-like structure around mostly PV+ cells (Valenzuela et al., 2014) . However, the precise source of BCAN remains unclear. We found that in the hippocampus, Brevican transcripts (Bcan) are restricted to glial and PV+ cells ( Figures 1A-1D and S1A-S1D). BCAN has different splicing isoforms encoding secreted (BCAN1) and GPI-anchored (BCAN2) proteins (Seidenbecher et al., 1995) .
We observed that whereas both isoforms were co-expressed in glia and PV+ interneurons, the latter population of cells showed a bias toward Bcan2 expression ( Figures 1D-1G ). The percentage of PV+ cells that expressed BCAN increased substantially in the second postnatal week, when the maximum fraction of BCAN+/PV+ cells was found ( Figures 1H, 1I , and S1E). BCAN kept accumulating around PV+ cells after the third postnatal week ( Figure S1F ). Interestingly, we observed that BCAN+/PV+ cells exhibit higher PV levels than BCANÀ/PV+ cells ( Figures 1J, 1K , and S2A). Of note, although Brevican is also expressed throughout the neocortex (Figures S1G and S1H) , no trace of BCAN was detected in chandelier cells (0 out of 9 cells, Figure S1B ).
It has been shown that PNNs ensheath synaptic contacts, suggesting a possible role during synapse formation (Hockfield and McKay, 1983) . We observed that the frequency and intensity of BCAN staining in PV+ cells increased concurrently with the development of synaptic inputs onto these cells (Figures S1E, S1F, and S1I). In the hippocampus, the soma of PV+ basket cells receives both excitatory inputs from pyramidal cells and inhibitory inputs from interneurons. Among these synapses, we found that BCAN was particularly enriched in excitatory terminals (VGlut1+) ( Figures 1L-1N ). In contrast, only a small percentage of inhibitory puncta (Syt2+ PV+ or GAD65+ PVÀ) contacting PV+ cells were BCAN+ ( Figures S1J-S1O ). To analyze the subcellular location of BCAN with nanoscale resolution in hippocampal sections, we developed a novel method for multi-color single-molecule localization-based super-resolution microscopy (Betzig et al., 2006) , termed SD-dSTORM (spectral-demixing stochastic optical reconstruction microscopy) (Winterflood et al., 2015) ( Figures 1O-1R and S1P-S1S). We first identified somatic synapses apposed to PV+ cells by immunolabeling the synaptic proteins Bassoon (pre-synapse) and Homer1 (postsynapse). As described before (Dani et al., 2010) , we observed typical focal planes with Bassoon and Homer1 flanking the synaptic cleft ( Figure 1P ). Using Bassoon as a reference, we focused on the axial distribution of BCAN and found that it was located both pre-and postsynaptically ( Figures 1O-1R ). Next, we observed that the average radial position of BCAN relative to the center of the synaptic complex is predominantly peripheral (Figures 1P and 1R) . Altogether, our findings reveal that BCAN-mostly BCAN2-is expressed in a large fraction of PV+ cells and that it flanks the excitatory synapses received by these cells.
Brevican Identifies a Subpopulation of PV+ Basket Cells PV+ basket cells comprise a highly diverse population of interneurons that integrate in multiple microcircuits and exhibit diverse firing patterns and molecular programs (Dehorter et al., 2015) . In addition to the different PV levels exhibited by BCAN+ and BCANÀ PV+ cells ( Figures 1J, 1K , and S2A), using pre-(VGlut1) and postsynaptic (PSD95) markers we found that BCAN+/PV+ cells receive a higher number of excitatory inputs than BCANÀ/PV+ cells (Figures 2A-2C , S2B, and S2C).
We then enquired whether BCAN+ and BCANÀ PV cells could be distinguished on the basis of their electrophysiological properties ( Figures 2D-2M ). BCAN+/PV+ cells are less excitable, showing lower input resistance than BCANÀ/PV+ cells (Figures 2I and Table S1 ). However, BCAN+/PV+ cells also seem better tuned to operate at higher spiking frequencies than their counterparts, as they display higher maximum firing frequency, less spike frequency adaptation, narrower action potential half-width, and an earlier fast after-hyperpolarization (fAHP) time than BCANÀ/PV+ cells ( Figures 2D-2M ). Our findings reveal that PV+ cells expressing BCAN have a distinct profile: they receive more glutamatergic synapses, are less excitable, and have faster responses than PV+ cells lacking BCAN. (R) Radial distribution of BCAN at the synapse. P(r)/r: probability density of localization at the radial position r. Analysis of 52 face-view synapses from 6 experiments. Full and open arrowheads show colocalization and no colocalization, respectively. Data are presented as mean ± SEM. Scale bars represent 10 mm (A-D), 20 mm (E, F, and H), 5 mm (J and M), 1 mm (N), 2 mm (O), and 250 nm (P). See also Figure S1 .
Brevican Controls Synapses and Intrinsic Properties of PV+ Basket Cells BCAN locates at the flanks of excitatory synapses and its peak of expression coincides with the maturation of these inputs to PV+ cells ( Figure S1I ). To test a potential function of BCAN in the wiring of PV+ cells, we analyzed the impact of BCAN deletion on the synaptic inputs these interneurons receive. Whereas the density of excitatory synapses impinging on the soma of PV+ cells and the levels of PV expression were comparable in control and Bcan mutant mice at early stages of synaptic development (postnatal day 15 [P15]), PV+ cells received less excitatory inputs in Bcan knockout mice at P30 ( Figures 3A-3D , S3A, and S3B). Consistently, Bcan mutants exhibited a lower frequency-but not amplitude-of miniature excitatory postsynaptic currents (mEPSCs), which also had a slower decay ( Figures 3E-3I ). These findings indicated that, although BCAN is dispensable for the initial contact of excitatory boutons with PV+ cells, it is critical for their maturation. Of note, we detected a reduction in PV protein levels at P30 but not at P15, while the total density of PV+ cells remained unaltered ( Figures 3J-3M and S3C ). We observed a similar reduction in the density of excitatory puncta in adult mice (P60; Figures  S3D-S3F) , which rules out a potential delay in synapse formation.
To test whether BCAN function is also required for the formation of perisomatic inhibitory synapses in PV+ cells, we examined inputs from other PV+ and Cholecystokinin-positive (CCK+) basket cells (Karson et al., 2009) . We observed that the density and size of Syt2+ (a presynaptic marker of PV+ cells) terminals contacting the soma of PV+ cells as well as the density of Syt2+/Gephyrin+ synapses were similar between both genotypes ( Figures S3G-S3K ). To analyze the contribution of CCK+ interneurons, we combined the GAD65 synaptic protein with the presynaptic receptor CB1, highly enriched in CCK+ axon terminals (Katona et al., 1999) . We found no significant differences in the density of (I-M) Intrinsic properties of BCAN+ (n = 22 cells, 9 mice) and BCANÀ (n = 13 cells, 9 mice) PV+ cells. AP, action potential; fAHP, fast after hyperpolarization; Max FF, maximum firing frequency. Student's t test except for (I) and (K) where Mann-Whitney test was used. In this and subsequent figures, *p < 0.05, **p < 0.01, ***p < 0.001, n.s., p > 0.05. Data are represented as mean ± SEM. Scale bars represent 1 mm (A and B) and 5 mm (D and F). See also Figure S2 and Table S1 . (J-L) Images (J and K) and cumulative probability plots (L) of PV fluorescence intensity in WT (n = 147 cells, 4 mice) and Bcan À/À (n = 164 cells, 4 mice).
(M) Density of PV+ cells in the CA1 region of the hippocampus in WT (n = 6) and Bcan À/À (n = 4) mice.
(N-U) Intrinsic properties (N-P and R), cumulative probability plot for the spike latency (Q) comparing WT (n = 63 cells, 10 mice) and See also Figure S3 and Table S1 .
GAD65+/CB1+ synapses between control and Bcan mutant mice ( Figures S3L-S3N ). Consistent with these results, we found no differences in miniature inhibitory postsynaptic currents (mIPSCs) (Figures S3O-S3S ). In agreement with its highly specific location at excitatory synapses, these results revealed that BCAN regulates the maturation of excitatory-but not inhibitory-inputs onto PV+ cells. Since BCAN+/PV+ cells exhibit different electrophysiological properties than BCANÀ/PV+ interneurons, we examined whether loss of BCAN would alter the intrinsic properties of BCAN+/PV+ cells. We found that PV+ interneurons in Bcan mutant mice exhibited broader action potentials with smaller fAHP phase ( Figures 3N-3V and Table S2 ). Consistently, the input-output curve was below that of Bcan +/+ cells ( Figures  3V) . Moreover, we found that deletion of BCAN enhanced the intrinsic excitability of PV+ cells by decreasing the action potential threshold and latency to first action potential (Figures 3O-3Q  and Table S2 ). To examine how the changes in the excitatory drive and excitability of Bcan mutant PV+ interneurons ultimately influenced the flow of information from pyramidal to PV+ cells, we recorded spontaneous excitatory postsynaptic currents (sEPSCs) in PV+ cells ( Figures S3T-S3X ). We observed a decreased frequency of sEPSCs and slower decay kinetics in Bcan mutant mice (Figures S3U and S3X) . Our findings therefore demonstrate that BCAN is necessary for the maturation of excitatory inputs onto PV+ interneurons, as well as for the expression of their normative intrinsic properties.
A Cell-Autonomous Function for Brevican in Parvalbumin Cells BCAN is found around the soma of PV+ cells, but its source is unclear, as is its precise cellular contribution to the Bcan mutant phenotype. To investigate this, we first explored whether celltype-specific knockdown of BCAN in PV+ interneurons was sufficient to mimic the synaptic and cellular phenotype found in Bcan mutant mice. We engineered Cre-dependent conditional constructs expressing a short-hairpin RNA (shRNA) targeting a common region for both Bcan1 and Bcan2 (shBcan, Figure S4A ). We packed this construct in adeno-associated viral vectors (AAV) in which recombination was reported by mCherry ( Figures  4A-4C) , and the functionality of these constructs was assayed in vitro ( Figures S4A-S4F ). We co-injected low titer Cre-dependent shBcan and YFP-expressing viruses into the hippocampal CA1 region of PV-Cre mice at P12 and analyzed the density of synapses in sparsely labeled PV+ cells at P30 (Figures 4A-4G ). Expression of shBcan led to a loss of BCAN in PV+ cells, causing a decrease in the number of excitatory-but not inhibitory-afferents onto knockdown (mCherry+) compared to control (YFP+) PV+ cells ( Figures 4C-4G , S4G, and S4H) and a shift toward lower PV levels ( Figure 4H ).
We next used a similar approach to explore how PV-specific loss of BCAN affects the intrinsic properties of PV+ cells. We found that PV+ cells that expressed shBcan mimicked Bcan mutants for some variables but with a stronger trend when compared to Bcan +/+ mice ( Figures 4I-4U and Table S3 ). Altogether, these experiments demonstrated that cell-autonomous expression of BCAN in PV+ interneurons controls their excitatory inputs and some of their intrinsic properties.
Isoform-Specific Roles for Brevican
To explore which BCAN isoform is required for the maturation of excitatory synapses, we attempted to rescue cell-autonomously the synaptic deficit observed in Bcan mutant interneurons by overexpressing Cre-dependent HA-tagged Bcan1 or Bcan2 in hippocampal PV+ cells ( Figures 5A-5C and S4B ). HA reported BCAN1 and BCAN2 expression accurately ( Figure S5A ). Remarkably, whereas BCAN1 resembled other classical PNN markers, BCAN2 expression was dotted, similar to that commonly observed for synaptic markers ( Figures 5D, 5I , and S5A). We observed that while Bcan1 expression does not rescue the synaptic phenotype found in Bcan mutant PV+ cells, Bcan2 does ( Figures 5E-5H , 5J-5M, and S5B-S5G). The synaptic function of BCAN2 required the GPI-anchor, since overexpression of a Bcan2 that lacks the GPI-domain led to an even more pronounced synaptic phenotype compared to BcanÀ/À mice (Figures S5D-S5F ). Interestingly, both Bcan1 and Bcan2 were able to rescue PV levels (Figures 5H and 5M) , suggesting that it could change both as a result of modifications in the excitatory drive of PV+ cells as well as by independent cellular mechanisms. Altogether, these results reveal an isoform-specific function for Bcan2 in the maturation of the excitatory synapses on PV+ interneurons.
Interestingly, we observed a milder reduction of excitatory inputs contacting Bcan knockdown compared to Bcan knockout PV+ cells ( Figures S4G and S5H) . Consistently, expression of Bcan2 in PV+ cells only partially rescued the density of VGlut1+ puncta ( Figure S5C ). As BCAN is also expressed in glial cells ( Figure 1 ) and astrocytes contribute to synapse development (Clarke and Barres, 2013), we attempted to rescue the Bcan mutant PV+ cells' wiring phenotype by driving Bcan1 or Bcan2 expression in astrocytes ( Figures 5N-5W ). BCAN1 was secreted from astrocytes and concentrated around both a small number of PV+ cells ( Figures 5Q, 5R , and S5I) and few pyramidal cells ( Figure S5J ), as described before for PNNs (Carstens et al., 2016) . BCAN2 was instead cleaved and released from astrocytes in the tissue without displaying any cell-type bias (Figures 5S and 5T) . When expressed in astrocytes, Bcan2-but not Bcan1-rescued the synaptic phenotype found in Bcan mutant PV+ cells ( Figures 5U-5X and S5M ). However, neither Bcan1 nor Bcan2 expression in astrocytes led to a rescue of PV levels ( Figure S5L ). Altogether, our results suggest that Bcan2 expression in PV+ cells regulates the maturation of their excitatory inputs, along with a potential contribution from astrocytes.
The marked alteration in the intrinsic properties of PV+ cells upon Bcan knockdown suggested a cell-autonomous role for BCAN in the regulation of the firing properties of PV+ cells. To determine whether this was due to the lack of a specific Bcan isoform, we asked whether expression of either Bcan1 or Bcan2 alone was sufficient to rescue the phenotype found in Bcan mutant mice ( Figures 5A-5C ). Our results revealed that none of the two isoforms was by itself sufficient to restore normative intrinsic properties in Bcan mutant mice ( Figures S5M-S5W and Table S4 ), suggesting that either both isoforms may cooperatively regulate the firing behavior of PV+ interneurons or a more complex scenario may be taking place. Brevican Controls AMPA Receptors and Voltage-Gated Potassium Channels in PV+ Cells Our results demonstrate that BCAN-more specifically, BCAN2-is necessary for the maturation ( Figure 3D ) but not initial assembly ( Figure S3B ) of excitatory synapses onto PV+ cells. These findings prompted us to investigate how BCAN may regulate the differentiation of excitatory synapses. During postnatal development, neurons edit the composition of their glutamate receptors (Hu et al., 2014) . This process is particularly important in PV+ interneurons, where transmission is primarily mediated by GluA2-lacking, calcium-permeable AMPA receptors (AMPARs) with GluA1 and GluA4 subunits (Fuchs et al., 2007; Matta et al., 2013) . The slower decay of mEPSCs and sEPSCs found in Bcan mutant mice suggested an altered subunit composition of AMPARs (Figures 3I and S3X) . To investigate whether BCAN may contribute to the regulation of AMPARs in PV+ cells, we performed co-immunoprecipitation (coIP) experiments in hippocampal lysates. We found that BCAN protein co-immunoprecipitated with different AMPAR subunits but not with NMDA or metabotropic glutamate receptors (Figures 6A and S6A) . We next examined whether BCAN is required for the expression of GluA1 and GluA4-containing AMPARs at synapses. Analysis of hippocampal synaptosome fractions obtained from Bcan mutant mice revealed a reduction of synaptic GluA1 compared to controls (Figures 6B, 6C, S6D, and S6E). This reduction was accompanied by an increase of GluA1 in the non-synaptic plasma membrane fraction, while no differences were observed in total or cytoplasmic GluA1 protein ( Figures 6B, 6C , S6D, and S6E). In contrast, levels of GluA4 were unchanged (Figures S6B and S6C) . Interestingly, although Bcan2-but not Bcan1-is responsible for the synaptic phenotype found in Bcan mutants (Figures 5G and 5L) , both BCAN1 and BCAN2 co-immunoprecipitated with GluA1 in vitro (Figure S6I) . Altogether, these results suggested that BCAN may be involved in the trafficking of GluA1 AMPAR subunits from extrasynaptic to synaptic sites.
Since GluA1 subunits are expressed in both pyramidal cells and interneurons, we sought to investigate the neuronal population responsible for the changes in GluA1 subcellular location. Using three-color STORM microscopy in brain sections of wild-type mice, we measured the radial position of BCAN and GluA1 in relation to the synaptic marker Bassoon contacting PV+ cells. We observed that BCAN and GluA1 partially overlap in the outer domain of Bassoon ( Figures 6D and 6E ). We next analyzed the density of GluA1+ synaptic clusters (Figures 6F-6M and S6F) and found a 50% reduction in Bcan mutant and Bcan knockdown PV+ cells ( Figures 6G, 6H , 6K, and 6L). Cell-type-specific loss of GluA1 is in itself sufficient to decrease the excitatory afferents onto PV+ cells, as the density of excitatory synapses was reduced in PV-Cre;GluA1 F/F mice compared to controls . This suggests that the PV-specific loss of GluA1 consequent to disruption of BCAN expression would suffice to produce a deficit in excitatory synaptic inputs. Consistent with the synaptic function of Bcan2, only this isoform's expression restored the density of synaptic GluA1+ clusters in Bcan mutant PV+ cells (Figures 6I, 6J, and 6M) . Our results thus demonstrate that BCAN regulates excitatory inputs contacting PV+ interneurons at least in part by controlling the normal localization and levels of GluA1 AMPAR subunits.
BCAN also regulates the electrophysiological properties of PV+ cells. Some such properties are regulated by fast-activating voltage-gated K + conductances mediated by K v 1 and K v 3 potassium channels (Hu et al., 2014) . We focused our analysis in the K v 1.1 and K v 3.1 subunits, which are enriched in PV+ cells and are key for the characteristics of their action potential waveform (Du et al., 1996; Goldberg et al., 2008) . We found that both BCAN1 and BCAN2 form protein complexes with K v 1.1 and K v 3.1b ( Figures S6H and S6I ). Consistently, we observed a prominent decrease in the density of K v 3.1b membrane clusters-but not in the total K v 3.1b protein-in Bcan-deficient PV+ cells ( Figures 6Q-6U ), which may support deficits in spike waveform, duration, and frequency found in the mutants ( Figures  3N, 3U , and 3V). We also found a decrease in the density of K v 1.1 membrane clusters in PV+ cells-as well as in K v 1.1 total protein-in Bcan mutant mice (Figures 6V-6Y), a finding that is consistent with the reduction in action potential threshold and latency observed in the mutants ( Figures 3O-3Q ). BCAN knockdown in PV+ interneurons also reduced the density of K v 3.1b but not K v 1.1 clusters in these cells (Figures 6S, 6U, 6X, and 6Z). Altogether, these results suggest that cell-autonomous expression of BCAN in PV+ cells controls fundamental properties of the action potential by regulating the composition of specific channels, including K v 3.1b-containing potassium channels.
Brevican Expression Is Dynamically Regulated by Activity AMPA glutamate receptors, particularly those containing GluA1 subunits, are recruited to the synapse in an activity-dependent manner (Henley and Wilkinson, 2016) but the molecular mechanisms by which they are trafficked to and held there are not fully understood (Turrigiano, 2012) . Since BCAN controls the expression of GluA1 at the synapse, we hypothesized that it might coordinate GluA1 subunit clustering by dynamically responding to changes in activity. To test this idea, we analyzed the expression of BCAN in three different experimental paradigms of altered network activity. First, we used pharmacology in hippocampal cultures: increasing activity with the GABA A receptor antagonist Gabazine led to a 47% decrease in BCAN levels (Figures 7A and 7B) . Reducing activity via L-type calcium channel blockade (Nifedipine) resulted in an increase in BCAN ( Figures 7A and 7B ). Second, we obtained tissue from surgical resections of patients with temporal lobe seizures, a pathological model of excessive neural activity. We observed that BCAN was decreased in epilepsy patients compared to controls, suggesting that BCAN levels are controlled by activity also in the human cortex ( Figures  7C and 7D ). This decrease was not due to a reduction in the number of interneurons, as protein levels for the interneuron marker Lhx6 were similar in both conditions (Figures S7A and S7B) .
To confirm that BCAN is dynamically regulated by activity under more physiological conditions, we analyzed changes in BCAN levels associated to training (Figures S7C and S7D) . Previous studies have shown shifts in cortical PV+ cell network configuration after learning (Dehorter et al., 2015; Donato et al., 2013) . Consistently, 4 days of Morris Water Maze (MWM) training caused a shift to low PV expression in PV+ cells ( Figure S7E ). During the learning phase of the task (day 4), BCAN expression also shifted to lower levels, leading to a decrease in the proportion of BCAN+ cells among the PV+ interneuron population (Figures 7E-7H ). Interestingly, upon learning accomplishment (day 10), PV expression shifted to a high-PV network configuration and BCAN expression returned to baseline levels . To strengthen these observations, we analyzed BCAN levels in mice exposed to an enriched environment (EE). We observed that 30 days of EE caused a shift to low PV expression compared to mice housed in standard conditions ( Figure S7J ). Consistent with a remodeling of the PV+ interneuron network, we also found that EE decreases the levels of BCAN compared to controls ( Figures 7I-7K) . Consequently, the percentage of BCAN+/PV+ cells was also reduced ( Figure 7L ). Such changes in the BCAN levels led to synaptic modifications onto PV+ cells (Figure 7M) , as observed in Bcan mutants ( Figure 3 ). We next demonstrated that both BCAN isoforms were regulated by activity. A decrease in both Bcan2 and Bcan1 levels was detected after only 4 days of EE ( Figures 7N and 7O ) when no change in the PV and BCAN levels or in the density of excitatory synapses were yet observed ( Figures S7K-S7O ). Noteably, the reduction of Bcan2-but not Bcan1-was still maintained after 30 days of EE ( Figures 7N, 7O , S7N, and S7O). Although both Bcan isoforms seem to be regulated by activity, the increase in the Bcan1/Bcan2 ratio suggests that Bcan2 may be the main isoform that responds to changes in activity ( Figure S7P ). Altogether, these experiments demonstrate that BCAN levels are dynamically regulated by activity under physiological conditions.
Brevican Mutants Have Cognitive Deficits
The activity-dependent dynamics of BCAN could be a critical mechanism for regulating plasticity during learning and behavior. GluA1-containing AMPARs are essential for several hippocampal-dependent forms of memory (Fuchs et al., 2007; Reisel et al., 2002; Sanderson et al., 2009 ). Since BCAN regulates GluA1 at excitatory synapses contacting PV+ cells (Figure 6 ), we next examined how the loss of BCAN affects learning and memory (Figures 8 and S8 ). We assessed spatial working memory on the T-maze and found a moderate impairment in Bcan mutant mice ( Figures 8A and 8B ) that resembles the phenotype of mice lacking GluA1 in PV+ cells (Fuchs et al., 2007) .
GluA1 mutants also exhibit impaired short-term spatial memory (Sanderson et al., 2007) . To assess whether the lack of BCAN leads to a similar phenotype, we used a novelty preference test on the Y-maze (Figures 8C-8H and S8E-S8L) (Sanderson et al., 2007) . As expected, control mice showed a strong preference for the novel arm ( Figures 8E-8H ). In contrast, Bcan mutant mice were incapable of discriminating between familiar and novel arms ( Figures 8E-8H ). Interestingly, when tested for novelty preference after incremental training ( Figures S8E-S8L ), Bcan mutant mice preferred the novel to the familiar arm, showing higher discrimination indexes than control mice (Figures S8K and S8L) .
In contrast to the short-term deficiencies, long-term memories seem to be enhanced in GluA1 mutants (Fuchs et al., 2007; Sanderson et al., 2009 ). Thus, we reasoned that alterations in GluA1 subunit mobility due to lack of BCAN might also alter memory consolidation. To explore this possibility, we designed a novel object recognition (NOR) protocol to consecutively assess the effect of BCAN deletion on short-term and longterm memories ( Figures 8I-8M , S8M, and S8N). After a short retention interval, we observed that while control mice preferred the novel over the familiar object, Bcan mutant mice devoted similar time to exploring both novel and familiar objects ( Figures  8J and 8K ). In contrast, Bcan mutants were able to remember the familiar object after a longer retention time and spent more time exploring the novel object ( Figure 8L ). Interestingly, the discrimination index was higher in Bcan À/À mice than in controls (Figure 8M) , suggesting potentially enhanced long-term memory in absence of BCAN. Since BCAN expression in astrocytes may contribute to the synaptic phenotype found in Bcan À/À mice (Figure 1 ), we next (N-P) Density (N), control (O) and mutant (P) images (upper panels), and thresholded masks (lower panels) of VGlut1+PSD95+ synapses (arrowheads) contacting PV+ cells in PV-Cre; GluA1 conditional mutants (n = 10 mice) compared to controls (n = 6 mice).
(Q and R) Blots (Q) and quantification (R) of K v 3.1b in WT (n = 5 mice) and Bcan À/À (n = 4 mice) hippocampal lysates. investigated whether the specific depletion of BCAN in PV+ cells was sufficient to cause short-term memory defects as observed in Bcan mutant mice. PV-Cre mice were injected at P12 with Credependent shBcan-or control YFP-expressing viruses into the dorsal hippocampus and spatial short-term memory was assessed at P60 by the novelty preference test ( Figures 8C, 8D , 8N-8Q, and S8O-S8S). We found that Bcan knockdown mice displayed the same short-term memory deficit exhibited by Bcan mutant mice , demonstrating that normal levels of BCAN specifically in PV+ cells are required for short-term memory. Altogether, these results demonstrate that BCAN regulates plasticity-dependent events that are essential for learning and memory.
DISCUSSION
Several studies have revealed a critical role for PNNs in experience-dependent plasticity, learning, and memory (Gogolla et al., 2009; Pizzorusso et al., 2002 Since the extracellular matrix (ECM) influences cell-cell interactions, it is conceivable that specific components of the ECM may promote cellular and synaptic plasticity in a cell-specific manner. ECM molecules and associated proteins have been shown to regulate receptor clustering and shape synaptic differentiation, function, and plasticity (Chang et al., 2010; Frischknecht et al., 2009; de Wit et al., 2013) . In this study, we have shown that PV+ interneurons expressing BCAN receive more glutamatergic inputs than similar cells lacking BCAN. Specifically, expression of the GPI-anchored isoform of BCAN by PV+ cells is responsible for regulating the density of their excitatory synapses. In addition, release of BCAN2 from astrocytes may also contribute to synapse maturation onto PV+ cells. While astrocytes are well known to critically regulate the development of glutamatergic inputs onto pyramidal neurons (Clarke and Barres, 2013), our results hint at a possible role for these cells at the excitatory synapses on the PV+ interneurons. Future studies will need to address their function on interneuron wiring in more detail. Intriguingly, although our findings show a distinct function for BCAN1 and BCAN2 at the synapses, both BCAN isoforms are able to shift PV levels. One conceivable explanation is that the levels of the calcium binding protein PV change in response to different mechanisms: modifications in both the excitatory drive of PV+ cells that may affect intracellular calcium concentration and the diffusion of local extracellular calcium. Consistently, PNNs are highly negatively charged and have been proposed to function as a buffering system for cations surrounding fast-firing neurons (Br€ uckner et al., 1993) .
BCAN affects excitatory synaptic differentiation, at least in part by modulating the levels of GluA1 receptor at the synapse. In absence of BCAN, GluA1 fails to cluster in postsynaptic densities and this seems to cause a loss of excitatory synaptic contacts onto PV+ interneurons. Since the specific depletion of GluA1 from PV+ cells causes a similar phenotype, it is unlikely that the reduction in GluA1 observed in Bcan mutants is due to the loss of synapses by a GluA1-independent mechanism. Nevertheless, it is conceivable that other proteins interacting with BCAN also contribute to the synaptic phenotype described in the present study. Further studies will be needed to elucidate the contribution of other BCAN partners to the maturation of these synapses.
BCAN identifies a dynamic population of PV+ interneurons that not only receives more excitatory synapses but also has distinctive intrinsic properties. PV+ cells expressing BCAN are less excitable, but they are more efficient once recruited. Consistently, we observed deficits in the K v 1.1 and K v 3.1b channels in absence of BCAN. Worth mentioning, in Bcan mutants, homeostatic adaptations of PV+ interneurons in response to the decreased number of excitatory inputs seem to trigger changes in Kv1.1. Conversely, a cell-autonomous decrease in Kv1.1 has been previously shown to cause homeostatic changes in connectivity (Dehorter et al., 2015) . Altogether, these data support a novel interesting notion that connectivity and cell excitability are reciprocally regulated at the circuit level. Nevertheless, ECM molecules have been implicated in synaptic plasticity through the regulation of ion channels (Kochlamazashvili et al., 2010) . As such, BCAN may directly regulate ion channel density, position, or function. Indeed, the changes in spike shape and Kv3.1b clustering appear more directly related with the absence of BCAN. Specifically, these properties seem to depend on BCAN expression in PV+ interneurons, as the PV+ cell-specific knockdown revealed a particularly strong and broad phenotype when compared to the full Bcan knockout that might be explained by the different timing of the experimental manipulations. The mature fast-spiking (FS) properties of PV+ interneurons emerge gradually over the first postnatal weeks and are ultimately determined by elaborate interactions among the complements of ion channels that they express (Okaty et al., 2009 ). Likewise, the first PNNs are observed around P7 and their maturation continues until P28 (Schweizer et al., 1993) . In Bcan mutant cells, the absence of BCAN during this maturational progression may lead to the compensatory activation of parallel gene expression programs, including the previously reported Neurocan upregulation (Brakebusch et al., 2002) . In Bcan knockdown cells, however, BCAN downregulation takes place after the emergence of most of their mature FS physiological features, therefore missing the precise time window for a potential compensation. The presence of developmental adaptations in Bcan mutant PV+ cells, might also explain why the relatively late expression of Bcan1 or Bcan2 is unable to rescue the electrophysiological phenotype. A complementary explanation is that the presence of both BCAN isoforms is required for PV+ cells to have normal intrinsic properties. Future work addressing the consequences of an earlier Bcan deletion and rescue, as well as the developmental emergence of FS properties in Bcan mutant PV+ cells, will help to further decompose the complex electrophysiological phenotype displayed by Bcan-deficient PV+ cells.
Growing evidence over the last two decades has shown that the synaptic expression of GluA1 is regulated by activity. For instance, activity-dependent AMPAR insertion at the synapse is the substrate for the expression of the synaptic scaling (Turrigiano, 2012). Interestingly, it was reported that the expression of CSPG proteins requires normal patterns of neural activity (Lander et al., 1997) . In the present study, we have shown that BCAN expression is up-or downwardly scaled in response to activity changes. Cortical networks are dynamically regulated by activity in vivo (Donato et al., 2013) , but little is known about how neurons sense and adapt to the dynamics alterations in network activity at the level of synapses and spiking properties. Recent studies have shown that some of these changes might be mediated by transcription factors (Bloodgood et al., 2013; Dehorter et al., 2015) , but the mechanisms through which external signals directly control this process have remained elusive. Here we expose a novel molecular mechanism that simultaneously mediates modifications in the intrinsic properties and synaptic inputs of PV+ interneurons and that is regulated by experience.
Our data provide evidence that BCAN, one of the major components of PNNs, allows PV+ cells to adapt their responses to different types of sensory experience. Specifically, BCAN plays a crucial role in spatial working memory and short-term episodic-like memory but is dispensable, if not obstructive, for long-term memory. How do assemblies of neurons encode and represent different types of memory? It is worth mentioning that BCAN is enriched in the soma and proximal dendrites of PV+ cells, suggesting that it might regulate specific inputs arriving to PV+ cells. Indeed, in the hippocampus, different inputs have distinct subcellular specificity (Klausberger and Somogyi, 2008) and are involved in different aspects of memory (Kitamura et al., 2015) . Experience could therefore drive context-specific activation of BCAN+/PV+ cells, where BCAN would contribute to strengthen their excitatory inputs and filter weak and asynchronous stimuli. This positive feedback loop might thus promote the synchronization of pyramidal neurons leading to the formation of short-term memories. On the contrary, prolonged sensory experience, such as that linked to an enriched environment, would attenuate the levels of the PNN protein BCAN. As a consequence, the excitatory drive onto PV+ interneurons would be reduced, further releasing pyramidal cells from inhibition and triggering the plastic rearrangements in the principal cell network that underlie memory consolidation.
A growing amount of research is aiming to reveal the relationship between PNNs, memory and cognition (Tsien, 2013) . The newly discovered function of BCAN in PV+ cell plasticity may represent a general principle through which activity-regulated PNN proteins orchestrate selective modifications in specific classes of neurons, thereby influencing network plasticity outcomes upon changes in the environment.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents may be directed to and will be fulfilled by the lead contact, Beatriz Rico (beatriz.rico@ kcl.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice Brevican À/À mice (Brakebusch et al., 2002) , PV-Cre (Hippenmeyer et al., 2005) , PV-Cre;GluA1 F/F (Fuchs et al., 2007) , VIP-Cre, and RCE (Jackson Laboratories #010908 and #032037), were maintained in a C57B/6 background (Charles River Laboratories); Nkx2.1CreERT2 mice (Jackson Laboratories #014552) were maintained in a 129S2/SV background and GIN mice (Jackson Laboratories #003718) were maintained in a FVB/NJ background. All experimental procedures were performed on male mice, except for the analysis of synapse density in PV-Cre;GluA1 F/F mice ( Figures 6N and S6G ) and of the intrinsic properties in Bcan knockdown PV+ cells ( Figures 4I-4U ) where mice of both sexes were used. Animals were maintained under standard, temperature controlled, laboratory conditions, or in an enriched environment with free access to colored tunnels, mazes, climbing materials, and running wheels. Mice were kept on a 12:12 light/dark cycle and received water and food ad libitum with the exception of the rewarded alternation test. Animal procedures were approved by ethical committees (IN-CSIC and King's College London) and conducted in accordance with Spanish and European regulations, and Home Office personal and project licenses under the UK Animals (Scientific Procedures) 1986 Act.
METHOD DETAILS Perfusions and Immunohistochemistry
Animals were deeply anesthetized with sodium pentobarbital by intraperitoneal injection and then transcardially perfused with PBS followed by 4% paraformaldehyde (PFA) in PBS. Brains were dissected out and postfixed for two hours at 4 C, cryoprotected in a series of sucrose-PBS solutions overnight at 4 C. Then, tissue was sectioned at 40 mm on a sliding microtome (Leica). Free-floating brain sections were permeabilized by incubating with 0.2% Triton X-100 in PBS for 1 hr and then blocked for 3 hr (0.3% Triton X-100, 1% Normal Goat Serum and 5% BSA), followed by incubation with primary antibodies in 0.3% Triton X-100, 1% Normal Goat Serum and 2% BSA overnight at 4 C. The next day, brains were rinsed in PBS and incubated with the appropriated secondary antibodies for 2 hr at room temperature, rinsed in PBS, and then incubated with DAPI. The following primary antibodies were used: mouse antiparvalbumin (1:1000, Sigma #P-3088), rabbit anti-parvalbumin (1:2000, Swant #PV-25); goat anti-parvalbumin (1:500, Swant #PVG-214); chicken anti-parvalbumin (1:500, SySy #195 006); guinea-pig anti-VGlut1 (1:2000, Millipore #AB5905), mouse anti-PSD95 (1:500, NeuroMab #70-028), guinea-pig and rabbit anti-Brevican (1:1000, a gift from R. Frischknecht), rabbit anti-GluA1 (1:1000, Millipore #04-855), mouse anti-HA (1:500, Covance #MMS-101P), rabbit anti-DsRed (1:500, Clontech #632496), anti-GFP (1:1000, Aves Lab #1020), mouse anti-GAD65 (1:500, Millipore #MAB351R), mouse anti-Synaptotagmin-2 (1:1000, ZFIN #ZDB-ATB-081002-25), goat anti-CB1 (1:400, Frontier Institute # CB1-Go-Af450), mouse anti-gephyrin (1:500, Synaptic Systems #147 011), mouse anti-Kv3.1b (1:1000, NeuroMab #75-041), mouse anti-Kv1.1 (1:500, NeuroMab #75-007).
Fluorescent In Situ Hybridization Histochemistry
For dual-color fluorescent in situ hybridization combined with immunohistochemistry, mice were perfused and brains were fixed overnight in 4% PFA in PBS followed by cryoprotection in 30% sucrose-RNase free PBS. 30 mm sliding microtome sections were mounted on RNase-free SuperFrost Plus slides (Fisher Scientific) with PBST (0.5%Tween20 in PBS), allowed to dry and postfixed in 4% PFA for 5 min. After three rinses with PBST, sections were treated with 5 mg/ml proteinase K in PBST (Invitrogen) for 5 min, briefly transferred to 4% PFA, and rinsed with PBST. Sections were then incubated for 1 hr at 62 C with hybridization solution (50% formamide, 10% dextran sulfate, 0.2% tRNA, 4% Denhardt's solution, 200 mM NaCl, 10 mM Tris, 5 mM NaH2PO4, 5 mM Na 2 HPO 4 , 5 mM EDTA, pH 7.5) and hybridized overnight at 62 C with 0.2-0.5 mg of digoxigenin (DIG)-labeled probes diluted in hybridization solution. The next day, sections were rinsed with 50% formamide, 0.5 3 SSC, and 0.5% Tween 4x30 min at 62 C and 1x30 min at room temperature. Sections were then blocked for 1 hr in 3% BSA, 20% blocking solution (Roche), 10% sheep serum in MABT (0.1 M maleic acid, 0.2 M NaOH, 0.2 M NaCl, 0.5% Tween) followed by incubation overnight at 4 C with anti-DIG antibody (1:5000; Roche) together with primary antibodies diluted in blocking solution. On the following day, sections were rinsed 12x15 min in MABT, incubated with secondary antibodies for 2 hr at room temperature, rinsed 6x5 min in PBS, and incubated with DAPI. Sections were then rinsed twice with detection buffer (Tris HCl 100mM, 100 mM NaCl 5M, 10 mM MgCl 2 pH 8) and incubated for 3 hr at room temperature in the dark with 2-hydroxy-3-naphthoic acid 2 0 -phenylanilide phosphate (HNPP)/Fast Red mix (Roche) diluted 1:100 in detection buffer. Sections were rinsed with PBS-EDTA buffer, briefly transferred to 4% PFA, and rinsed twice with PBS. Then, sections were allowed to dry and covered with Mowiol/DABCO. Images were acquired in the following two days on an inverted Leica TCS-SP8 confocal with a 40x objective. The following DIG-labeled probes were used: Bcan (IMAGE: 5695027; GenBank: BC052032.1), Bcan1 (primers: 5 0 -TGCACCCCTGAGGAGCAAGAC-3 0 and 3 0 -CGGGTAAAACCTGAGGCCC TTGTG-5 0 ) and Bcan2 (primers: 5 0 -GTAATTCTGCTGAAGGCTCAA-3 0 and 3 0 -TGGGTACAAAGCAGTTTAATACAG-5 0 ). The probes used to detect the specific Bcan isoforms were obtained by RT-PCR amplification of P30 mouse hippocampal cDNA. The purified PCR product was A-tailed and cloned into the pGEMT-easy vector (Promega). The following primary antibodies were used: rabbit anti-parvalbumin (1:500, Swant #PV-25), rabbit anti-Olig2 (1:250, Millipore #AB9610), mouse anti-GFAP (1:500, Sigma #G3893).
Super-Resolution Image Acquisition and Analysis
For super-resolution imaging, mouse brains were fixed overnight in 4% PFA in PBS and cryoprotected in 30% sucrose-PBS. 20 mm sliding microtome sections were stained following immunohistochemistry procedure. The following primary antibodies were used: guinea-pig anti-Brevican (1:1000, a gift from R. Frischknecht), mouse anti-Bassoon (1:500, Abcam #ab82958), rabbit anti-Homer1 (1:400, Synaptic Systems #160 002), rabbit anti-GluA1 (1:1000, Millipore #04-855). Image Acquisition Single-molecule localization microscopy was performed on a custom-built setup as previously described (Platonova et al., 2015) . In brief, a 473 nm laser (100 mW, Laserglow Technologies) was used for activation and a 643 nm laser (150 mW, Toptica Photonics) for imaging. Both lasers were focused onto the back-focal plane of an Olympus NA 1.49, 60x, TIRF-objective. A quad-edge dichroic beamsplitter (405/488/532/635 nm, Semrock) was used to separate fluorescence emission from excitation light. Emission light was filtered by two bandpass emission filters (700/75 nm, Chroma) and a long pass dichroic beamsplitter (690 nm, AHF Analysetechnik) was used to split the emission light. The emission was dually focused by two separate 500 mm tube lenses and onto a backilluminated EM-CCD chip (Evolve, Photometrics) which was liquid-cooled to À80 C. Focusing was done by moving the objective with a piezo objective positioner (MIPOS100, Piezo Systems Jena). A focus lock was implemented by an electronic feedback loop (LabView, National Instruments), based on total internal reflection of a red laser at the coverslip and its detection on a quadrant photodiode. The z stability was better than ± 10 nm over several hours. For SMLM imaging, the switching buffer consisted of 0.1 M MEA/0.2 M Tris, pH 8.0 with 5% (w/v) glucose, 0.25 mg/ml glucose-oxidase and 20 mg/ml catalase. The imaging laser intensity of the 643 nm laser line used was $2 kW/cm 2 . To keep the average number of localizations per frame constant (maximum intensity $0.5 kW/cm 2 ), the intensity of the 473 nm activation laser was automatically adjusted. Imaging was performed in objective-type total internal reflection fluorescence (TIRF) mode. We recorded a minimum of 30,000 frames with an exposure time of 20-35 ms. All data analysis was performed in MATLAB (Mathworks). The acquired raw camera frames were filtered using a running median filter, a 50 frame filter radius and a keyframe separation of 20 frames. Single-molecule positions were determined by Gaussian fitting based on a maximum likelihood estimator and only localizations with a maximum localization precision of 15 nm and a maximum PSF of 180 nm (1/e-intensity) were considered for further analysis. An image-correlation based drift-correction was employed. The first 25 frames of the dSTORM acquisition were used for a coarse estimate of the translational shift between the left and right side of the EMCCD chip. This was done using the phase difference of the Fast Fourier Transform, which was calculated using a pixel-reconstructed image from the single-molecule localization coordinates using a pixel-size of 100 nm. The localizations from the short-wavelength channel were coarsely mapped onto the localizations of the long-wavelength channel and paired. For pairing the localizations of the two channels in each frame had to be within a maximum search-radius of 8 camera pixels ($800 nm). The paired localizations were used to calculate an affine transformation matrix using the MATLAB built-in routine cp2tform. The transformation matrix was used to map the localizations from the short-wavelength onto the localizations of the long-wavelength channel. The overall registration precision was 25-35 nm. The localizations were paired again, but using a more stringent cut-off of 1 pixel for the search-radius. The normalized intensity ratio was calculated for all localization pairs for the color-assignment using r = (I l ÀI s )/(I l +I s ), where I l and I s are the fluorescence intensities determined by maximum-likelihood fitting for the long and short wavelength channels, respectively. The localization pair was assigned to AF647, CF660C or C680 by manually selecting the ranges for the normalized intensity ratio. Examples for the dye separation are provided in Figure S1 .
Data analysis
Individual synapses contacting the soma of PV cells were manually selected from three-color dSTORM images. To determine the distribution between pre-and post-synaptic site ( Figure 1M ), ''side'' view synapses were chosen such that Bassoon and Homer1 were seen as parallel stripes. A line along the center of the pre-synaptic Bassoon was drawn manually (position = 0 nm). The synapses were overlaid with Bassoon = 0 and Homer1 was used to determine the orientation of the synapse. The longitudinal profile of Bassoon/Brevican/Homer1 across the synapse was then determined straightforwardly. For the radial distribution analysis of Bassoon/Homer1/Brevican ( Figure 1N ) and Bassoon/GluA1/Brevican ( Figure 5H ), ''face'' view synapses were chosen such that Bassoon/Homer1 and Bassoon/GluA1 were seen as overlapping round or elliptical discs. The mean x,y position of the Bassoon localizations of each synapse (simplified and considered to be radially symmetric) was set to x,y = 0,0. The Euclidian distance of the Bassoon/Homer1/Brevican and Bassoon/GluA1/Brevican localizations was used to compute their radial distribution for each synapse. The two-color radial distribution analysis of Brevican with respect to Bassoon ( Figure S1R ) or Homer1 ( Figure S1S ) was done correspondingly, except that in the latter case the mean x,y position of Homer1 localizations was used to establish x,y = 0,0.
Cell Culture, Transfection, Pharmacology and Immunocytochemistry Cell line cultures HEK293FT cells were cultured in Dulbecco's Modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM glutamine, penicillin (50 units/ml) and streptomycin (50 g/ml). The cultures were incubated at 37 C in a humidified atmosphere containing 5% CO 2 . HEK293FT cells were transfected using polyethylenimine (PEI, Sigma) at a 1:4 DNA:PEI ratio.
Primary hippocampal cultures
Hippocampi from E18 mouse embryos (both sexes) were dissected in ice-cold Hank's Balanced Salt Solution (HBSS), digested with 1cmg/ml trypsin (Worthington) for 15 min at 37 C, treated with 0.1 mg/ml DNase I (Roche) and triturated to produce a single cell suspension. Cells were then plated at 100,000 cells/cm 2 on plastic dishes. Cells were cultured in Neurobasal (Invitrogen) supplemented with 2% B27 (Invitrogen), glutamine (2 mM) and 100 mg/ml penicillin-streptomycin (GIBCO). For in vitro activity manipulations, 26DIV neuronal cultures were treated for 48 hr with 20 mM Gabazine or 20 mM Nifedipine, or their appropriated controls (H 2 O, and DMSO, respectively). Immunocytochemistry HEK293FT cells were fixed in 4% PFA/1% sucrose in PBS for 10 min, briefly washed in PBS and permeabilized with 0.2% Triton X-100 in PBS. Coverslips were blocked with 5% BSA in PBS for 1 hr and incubated with primary antibodies in blocking solution overnight at 4 C. Coverslips were then washed 6x5 min in PBS and incubated with secondary antibodies in blocking solution for 1h at room temperature. Coverslips were then washed 6x5 min in PBS, incubated with DAPI and mounted in Mowiol/DABCO. Primary antibodies used: chicken anti-GFP (1:3000, Aves Lab #1020), guinea-pig anti-Brevican (1:2000, a gift from R. Frischknecht), rabbit antiBrevican (1:2000, a gift from R. Frischknecht), rabbit anti-DsRed (1:500, Clontech #632496), mouse anti-HA (1:500, Covance #MMS-101P).
Generation of AAV Expression Vectors
To generate the pDIO-shBCAN-mCherry, the sequence containing the distal and proximal elements of the U6 promoter spaced by the CDS for mCherry was amplified by PCR. The resulting PCR product was cloned into the pAAV-EF1a-DIO-mCherry vector (a gift from Prof. K. Deisseroth, Addgene plasmid #20299) and a TATA box was introduced in the U6 fragment (primer sequences and cloning details will be provided elsewhere). The ssDNA primers to generate the shBCAN (5 0 -CTAGGCAAG CAGAACCGCTTCAATGCCTGACCCACATTGAAGCGGTTCTGTTGCTTTTTG-3 0 and 3 0 -AATTCAAAAAGCAAGCAGAACCGCTTCA ATGTGGGTC AGGCATTGAAGCGGTTCTGCTTGC-5 0 ) were obtained using the Block-it RNAi web tool (Thermo Scientific). To minimize the putative off-target effects of the shRNA, a miR-133 derived loop sequence was used (Gu et al., 2012) . Moreover, the shRNA sequence was blasted and no other mouse mRNA apart from Bcan was predicted to be targeted. The coding sequences for Bcan1 and Bcan2 full-length used in the rescue experiments were obtained from P30 mouse hippocampal cDNA and cloned into the pGEMT-easy vector (Promega). A canonical HA tag sequence was introduced after the signal peptide (primers: 5 0 -TCTAGAGC CACCATGATACCACTGCTTCTGTCCCT GCTGGCCGCTCTGGT-3 0 and 3 0 -TTGGGTCAGGACCAGAGCGGCCAGCAGGGA CAG AAGCAGTGGTATCATGGTGGCCTAGAA-5 0 ; 5 0 -CCTGACCCAAGCCCCTGCCGCCCTCGCTGATTACCCATACGATGTTCCAGATTA CGCTAGATCTA-3 0 and 3 0 -AGATCTAGCGTAATCTGGAACATCGTATGGGTAATCAGCGAGGGCGGCA GGGGC-5 0 ) and cloned in the pAAV-EF1a-DIO-mCherry vector. To generate a Bcan2 mutant that lacks the GPI anchor (BCAN2-GPI), the DNA sequence coding for the protein region containing the C-terminal GPI-modification sites was removed from Bcan2 full-length (PSSGNSAEGSM PAFLLFLLLQLWAT, best predicted site is shown in bold and is underlined, the alternative site is underlined).
AAV Production and Intracranial Injections
HEKs 293FT cells (ThermoScientific) were seeded on 15-cm plates and co-transfected with packaging plasmids AAV-ITR-2 genomic vectors (7.5 mg), AAV-Cap8 vector pDP8 (30 mg; PlasmidFactory GmbH, Germany, #pF478) using PEI (Sigma) at a ratio 1:4 (DNA:PEI). 72 hr post transfection, supernatants were incubated with ammonium persulfate (65 g/200 ml supernatant) for 30 min on ice and centrifuged for 45 min at 4000 RPM at 4 C. Transfected cells were harvested and lysed (150mM NaCl, 50mM Tris pH8.5), followed by three freeze-thaw cycles and Benzonase treatment (50U/ml; Sigma) for 1 hr at 37 C. Filtered AAVs (0.8 mm, 0.45 mm and 0.2 mm MCE filters) from supernatants and lysates were run on an iodixanol gradient by ultracentrifugation (Vti50 rotor, Beckmann Coultier) at 50,000 RPM for 1 hr at 12 C. The 40% iodixanol fraction containing AAV was collected, concentrated using 100 kDa-MWCO Centricon plus-20 and Centricon plus-2 (Merck-Millipore), aliquoted and stored at À80 C. The infectious titer of virus was measured by quantitative real-time PCR (primers: 5 0 -GGCACTGACAATTCCGTGGT-3 0 and 3 0 -CGCTGGATTGAGGGCCGAA-5 0 ). AAVs with a titer equal or higher to 10 11 genome copy/ml were used for in vivo injections. The AAV9-EF1a-DIO-eYFP was generated by and acquired from the Penn Vector Core, with a titer of 3.95 3 10 13 genome copy/ml. The AAV8-GFAP(0.7)-EGFP-T2A-iCre was generated by and acquired from the Vector Biolabs, with a titer of 5.6 3 10 13 genome copy/ml.
For intracranial injections, P12 mice were anesthetized with isoflurane and were mounted in a stereotactic frame. For synapse analysis, 250 nL of AAV8-shBcan-mCherry:AAV9-YFP in a 10:1 ratio, AAV8-Bcan1-HA:AAV9-YFP in a 10:1 ratio, AAV8-Bcan2-HA:AAV9-YFP in a 10:1 ratio, AAV8-Bcan2-HA:AAV8-GFAP-iCRE in a 1:1 ratio or AAV8-Bcan2-HA:AAV8-GFAP-iCRE in a 1:1 ratio were unilaterally injected into the dorsal region of the left hippocampus (anteroposterior À2.8cmm; mediolateral +1.2cmm; dorsoventral À1.3cmm relative to Bregma) at an injection rate of 50 nl/minute followed by 2 additional minutes to allow diffusion.
For electrophysiology or behavioral experiments we performed injection of high titer Cre-dependent viruses. Specifically, 400 nL of AAV8-shBcan-mCherry:AAV9-YFP in a 10:1 ratio, 400 nL of AAV8-Bcan1-HA:AAV9-YFP in a 10:1 ratio or 400 nL AAV8-Bcan2-HA:AAV9-YFP in a 10:1 ratio (for electrophysiology experiments) or 500 nL of AAV8-shBcan-mCherry or 500 nL of AAV9-YFP (for behavioral experiments) were bilaterally injected into the dorsal region of the hippocampus (anteroposterior À2.5, À2.8, À3.2cmm; mediolateral +1.2cmm; dorsoventral À1.3cmm relative to Bregma) at an injection rate of 100 nl/minute. Post-recording immunocytochemistry was carried out to evaluate the recorded cell and/or the expansion of the injection. For behavior, the injections massively targeted the majority of the PV cells in the dorsal hippocampus (data not shown).
Western blot and Fractionation
For western blot analysis on neuronal cultures, DIV28 E17.5 hippocampal cultures or HEK293FT were placed on ice and rinsed 1x in PBS. For western blot analysis on mouse tissue, P30 hippocampi were rapidly dissected in ice cold PSB. Samples were homogenized in lysis buffer containing 25 mM Tris-HCl pH 8, 50mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.001% SDS and protease inhibitor cocktail. For anti-Brevican western blot, samples were digested with 1.7U/mg of ChABC (Sigma) for 2 hr at 37 C. For fractionation experiments, Syn-PER Synaptic Protein Extraction Reagent (ThermoScientific) or Subcellular Protein Fractionation Kit for Tissues (ThermoScientific) were used according to the manufacturer's instructions. Protein quantity was measured using bicinchoninic acid (BCA) assay (ThermoScientific). All samples were denatured, resolved by SDS-PAGE and transferred onto PVDF membranes. Membranes were blocked with 5% nonfat milk (Biorad) in TBST (20mM Tris-HCl pH7.5, 150mM NaCl and 0.1% Tween20) for 1 hr and probed with the following primary antibodies: mouse anti-PSD95 (1:500, NeuroMab #70-028), guinea-pig and rabbit anti-Brevican (1:1000, a gift from R. Frischknecht), rabbit anti-actin (1:1000, Sigma #A2066), rabbit anti-GluR1 (1:1000, Millipore #04-855), mouse anti-GAPDH (1:1000, Sigma # G8795), rabbit anti-T-cadherin (1:500, Millipore #ABT121), rabbit anti-Na,KATPase (1:1000, Abcam, #ab76020), mouse anti-HA (1:500, Covance #MMS-101P), mouse anti-Kv1.1 (1:500, NeuroMab #75-007). After incubation with HRP-conjugated secondary antibodies, protein levels were visualized by chemiluminescence. Blots were scanned using a LI-COR OdysseyÒ Fc Imaging System and band were quantified with Image Studio Software. For quantification, densitometry of protein bands of interest was normalized to that of actin.
Co-immunoprecipitation Assays 100 mg of hippocampal homogenates from P30 mice or, for Brevican isoform-specific coIP, 100 mg of hippocampal homogenates from P30 Bcan mutant mice were mixed with 50 mg of lysate from HEK293FT co-transfected with CreGFP and a Cre-dependent Bcan1-HA or Bcan2-HA expressing plasmid were used. The lysate was then diluted in 1 mL of coIP buffer (0.3M sucrose, 10 mM Tris-HCl pH 8, 10 mM NaCl, 3 mM MgCl 2 , 1% NP-40, 5% glycerol and protease inhibitor cocktail) and subsequently incubated overnight at 4 C with 2 mg of one of the following antibodies: rabbit anti-GluR1 (Millipore #04-855), rabbit anti-GluR2-3 (Millipore #AB1506), rabbit anti-GluR4 (Millipore #AB1508), rabbit anti-NMDAR2B (Millipore #AB1557P), Rabbit IgG-Isotype Control (Abcam #ab27478), rabbit anti-mGluR2-3 (Millipore #AB1553), mouse anti-Kv1.1 (NeuroMab #75-007), mouse anti-Kv3.1b (NeuroMab #73-041), Mouse IgG-Isotype Control (Abcam # ab37355). 50 mL of protein A-Sepharose (Sigma) bead slurry was washed in coIP buffer and added to the mixture. After overnight incubation at 4 C with gentle rotation, the beads were pelleted and rinsed three times with coIP buffer. Immune complexes were then analyzed by western blot.
In vitro Patch Clamp Recordings
Slice preparation Postnatal day (P) 26-38 mice were deeply anesthetized with sodium pentobarbital and transcardially perfused with ice-cold sucrosebased cutting solution containing (in mM): 70 Sucrose, 86 NaCl, 4 KCl, 1 NaH 2 PO 4 , 7 MgCl 2 , 26 NaHCO 3 , 25 Glucose and 0.5 CaCl 2 . After brain dissection, 300 mm coronal hippocampal slices were cut using a vibratome (Leica) in the same ice-cold solution. After cutting, slices were transferred to an incubation chamber filled with artificial cerebrospinal fluid (ACSF) heated to 34 C and containing (in mM): 127 NaCl, 2.5 KCl, 0.6 NaH 2 PO 4 , 26 NaHCO 3 , 13 Glucose, 1.3 MgSO 4 , 2 CaCl 2 . Slices were kept in this heated chamber for 30 min and then transferred to a second chamber containing the same solution at room temperature, where they were kept for an additional 30 min, and throughout the day, before recordings.
Patch clamp recordings
After recovery, slices were transferred to a recording chamber continuously superfused with ACSF heated to 34 C. PV interneurons were viewed with infrared-differential interference optics (Hamamatsu camera controller) and fluorescence illumination (Cool Led 473nm) through a 40x water-immersion objective (Olympus). Patch microelectrodes (4-8 MU) were pulled from borosilicate glass (1.5 mm outer diameter x 0.86 mm inner diameter; Harvard Apparatus) using a vertical P10 puller (Narishige). Current-clamp and voltage-clamp (sEPSC) recordings were performed using an intracellular solution containing, in mM, 130 KGluconate, 5 KCl, 10 HEPES, 2 MgCl2, 10 Sodium Phosphocreatine, 2 Na2-ATP and 0.4 Na-GTP, as well as 1 mg/ml neurobiotin. sEPSCs were recorded at a holding potential of À70 mV. During current-clamp recordings, membrane potential was biased toward À65 mV. Cells were kept under current-clamp or voltage-clamp configuration with a Multiclamp 700B amplifier operating in fast mode. For mEPSC and mIPSC recordings, the following intracellular solution was used (in mM): 135 Cesium Methanesulfonate, 8 KCl, 10 HEPES, 0.4 Mg-ATP, 2.0 Na2-ATP, 0.5 EGTA, 0.6 Na-GTP. 1 mM TTX was added to the bath. mEPSCs were recorded at À60 mV and mIPSCs at +10 mV, accounting for an estimated liquid-junction potential of 10.4 mV. No pharmacological blockade of transmission was performed, in order to allow recording mEPSCs and mIPSCs from the same cell. Data were filtered on-line at 2 kHz, and acquired at a 20 kHz sampling rate for current-clamp recordings in Figure 2 and 50 kHz for all others using pClamp 10.7.0 software (Molecular Devices). For immunohistochemistry after patch clamp recording, slices were immediately drop-fixed in PFA 4% at room temperature for 30 min and subsequently transferred into PBS with 0.05% sodium azide. For BCAN+ and BCAN-cells, only one cell was recorded per slice, as to allow for unequivocal identification between immunohistochemical staining and electrophysiological recording. Data analysis Intrinsic properties were measured rapidly after obtaining whole-cell configuration, through injection of a series of depolarizing or hyperpolarizing 500 ms current steps were used at 0.5 Hz. Resting membrane potentials were measured just after patched membranes were ruptured by suction. Input resistance and membrane time constants were determined by passing hyperpolarizing current pulses inducing voltage shifts of 5-15 mV negative to resting membrane potential. Time constants were measured by fitting voltage responses with a single exponential function. Action potential (AP) threshold was determined as the voltage at which slope trajectory reached 20 mV/milliseconds. AP widths at half amplitude were measured for spikes elicited by depolarizing current pulses of threshold strength. Rheobase was determined by initially injecting positive current generating near-threshold 15-25 mV depolarizations and subsequently applying 1 pA current steps until APs were elicited. Rheobase was considered to have been reached once three such steps consecutively produced an AP, with the lowest value of the AP-generating injected currents used. Delay to first AP was measured during the same procedure, as the time elapsed between onset of current injection and AP threshold and was calculated from the average of 4 repetitions of this procedure. AP height was calculated as the difference in membrane potential between AP threshold and the peak. Afterhyperpolarisation (AhP) amplitude was defined as the difference between AP threshold and the most negative potential attained within 5 ms of AP threshold. AhP time was defined as the time elapsed between this point and AP threshold. For Bcan À/À recordings, since a change in AP threshold occurred, we corrected AhP amplitude accordingly. Saturating firing frequency and input-output curves were obtained by injecting steps of 100 pA current and counting spike number. AP frequency adaptation was calculated as the percent change in spike frequency during the last 100 ms of the spike train compared to the first 100 ms. For voltage sag, a hyperpolarising current pulse of 500 ms duration was injected to bring a subset of recorded neurons to a membrane potential of approximately À100 mV. Voltage sag was calculated by subtracting a cell's membrane potential at steady-state (median voltage during last 10 ms of current injection) from the minimum potential recorded during the first 100 ms of current injection. Synaptic currents were analyzed semi-automatically with Mini-Analysis (Synaptosoft), using detection parameters of 7 pA for event threshold, 10 ms for searching for a local maximum, 5 ms to search for baseline before peak, 50 ms to search for decay time and 0.37 as the fraction of peak amplitude to find a decay time. Rise-time was calculated as time elapsed between 10 and 90% of peak amplitude.
Image Acquisition and Analysis
Samples belonging to the same experiment were imaged during the same imaging session on an inverted Leica TCS-SP8 confocal. Imaging was performed with the same laser power, photomultiplier gain, pinhole, and detection filter settings (1024x1024 resolution, 12 bits or 16 bits). For cell co-localization analyses, confocal image stacks (40X oil immersion objective, 1.4 NA, 0.2 mm step size) were used to create maximum intensity projections and analyzed using a custom macro in Fiji (ImageJ) software. For Brevican and PV level analyses, Cy3 and AF647 fluorophores were used, respectively, and confocal image stacks (40X oil immersion objective, 1.4 NA, 0.2 mm step size) were reconstructed and analyzed with IMARIS 7.5.2 software. PV neurons whose soma was included within the tissue sections with optimal staining were isolated in three dimensions. Three-dimensional isosurfaces were created around each PV-neuron soma using the ''create surface'' tool and volume and labeling intensities were quantified automatically. A threshold was selected to include as much of the neuron as possible while excluding any background. A size filter was applied with the minimum size being related to the volume of the PV cell. The PV surface was then used to define the cellular domain and create three-dimensional isosurfaces around the PV neuron in the Brevican channel. The threshold was selected so as to have no surface reconstruction outside the cellular domain of PV cells. Brevican volume and intensity were quantified automatically. For synaptic puncta/cluster analysis, images of z-planes with optimal staining of synaptic markers were acquired (100X oil immersion objective, 1.44 NA, 2.2 digital zoom). Analysis of excitatory and inhibitory synapses contacting PV cells was carried out in the stratum oriens of the CA1 region of the hippocampus. Analysis of synaptic puncta/cluster densities was performed using a custom macro in Fiji (ImageJ) software.
Processing of all channels included background subtraction, Gaussian blurring, smoothing, and contrast enhancement. All single channel images were converted to RGB. For the PV soma, a color threshold was selected to identify the cell soma. The border of the soma was automatically or manually drawn to automatically calculate its perimeter and create a mask with the cell body only. For the presynaptic boutons or postsynaptic clusters, a color threshold was selected to include as many putative synapses as possible while excluding any background. The same threshold in each channel was applied to all images from the same experiment. The ''Analyze Particles'' (size 0.10-infinity, circularity 0.00-1.00) and ''Watershed'' tools were applied and a mask was generated.
A merged image from all masks was created. Presynaptic boutons were defined as such when they were located outside the perimeter border but had R 0.1 mm 2 colocalizing with the mask of the soma. The criterion to define postsynaptic clusters was that R 0.2 mm 2 of the cluster area in the mask was located inside the perimeter border of the soma. Synapses were counted when an identified postsynaptic cluster was contacted by a presynaptic terminal (i.e., they had R 1 pixel colocalizing) or when an identified presynaptic bouton was contacting (i.e., they had R 1 pixel colocalizing) a postsynaptic cluster with R 1/4 of its area located inside the perimeter border of the soma. For the four-color analysis of GluA1-containing synapses, GluA1 clusters in PV cells were considered located at the synapse when colocalizing with a PSD-95 postsynaptic cluster that was contacted by a VGlut1 presynaptic terminal. For the correlation analysis shown in Figure S2B , confocal image stacks (100X oil immersion objective, 1.4 NA, 2.2 digital zoom, 0.2 mm step size) were reconstructed and analyzed with IMARIS 7.5.2 software. The PV cell soma was reconstructed with the ''create surface'' tool as described above. The VGlut1 presynaptic boutons and the Brevican coats were detected with the ''spot'' tool using a spot diameter of 0.68 mm for the VGlut1 boutons and of 0.5 mm for the Brevican coats. A threshold was selected to accurately detect as many spots as possible without creating artifacts. The radius of the spot was used as a threshold distance to define the contact and the ''Find spots close to surface'' tool (ImarisXT extension) was then used to count the number of presynaptic VGlut1 and Brevican spots that were contacting the surface of the soma.
In utero electroporation and Tamoxifen Induction CA1 pyramidal cells were labeled by in utero electroporation of a GFP plasmid in NEX-Cre mice. Pregnant females were anesthetized with isofluorane. The uterine horns were exposed and embryos were injected through the uterus wall using pulled capillaries filled with DNA (1.5cmgcml-1) diluted in PBS and colored with Fast Green (0.5%) (Sigma). Brain ventricles were filled with DNA solution (pCAGGS-IRES-GFP) and electroporated (CUY21/CUY650P3/ CUY650P5, Nepa Gene) using a program of 45cV, 50cms, 950cms, and five pulses. Tamoxifen was dissolved in corn oil (10 mg/ml) at 37 C with constant agitation. Chandelier cells (ChCs) were labeled by intragastric tamoxifen injections of P2 post-natal Nkx2.1CreERT2;RCE mouse pups at a dose of 1mg/10 g of body weight.
Quantitative real-time PCR Total RNA was extracted from mouse hippocampi using TRIzol reagent (Invitrogen) followed by DNase I treatment (Promega). cDNA synthesis was performed using the SuperScript IV First-Strand Synthesis System (Invitrogen) according to the manufacturer's protocol. qPCR was carried out in triplicates on a LightCycler 480 Instrument (Roche) using SYBR Green PCR Master Mix (Roche). Normalized mRNA levels for Bcan1 and Bcan2 relatively to those of Syt2 or Gfap were calculated using the comparative C T method. The sequences of qPCR primers were as follows: Bcan1 (Fw: CTATGTTTGCCAGGCTATGGGGG, Rv: TGCCTCCTCCCAACT CCTTCGTG), Bcan2 (Fw: GTCCTGGCAGGCACCTCAGTG, Rv: GCATTGAGCCTTCAGCAGAATTAC), Syt2 (Fw: ACGTGCCCA CAGCTGGGAAGCTC, Rv: GTCTCTTACCGTTCTGCATCAGG), Gfap (Fw: GGGACAACTTTGCACAGGACCTC, Rv: GGTGGCTTC ATCTGCCTCCTGTC). The activity-dependent gene Npas4 (Fw: TTCAAGCCAAGCATGGAGGCTGG, Rv: TAGCTGCTGGCG GAGGCTCCAGG) (Bloodgood et al., 2013) , was used to confirm the increase in activity in the enriched environment experiment.
Epilepsy human samples
Frozen postmortem brain tissue from individuals with epilepsy and controls was kindly supplied by the MRC London Neurodegenerative Diseases Brain Bank. Brain tissue of both sexes and age between 54 and 80 years old was used in the study. Control brains were from individuals with no history of epilepsy or psychiatric disease. The use of human sections was covered by ethics approval granted to the London Neurodegenerative Diseases Brain Bank. For biochemical analysis, 50 mg of tissue from the CA1 region of the hippocampus were homogenized in lysis buffer and processed following western blot procedures as described above.
Behavioral procedures
Animals were maintained under standard, temperature controlled, laboratory conditions and kept in 12 hr light-dark cycles with ad libitum access to food and water with the exception of the rewarded alternation test. For all behavioral tests, mice were housed singly and assessed during the light phase of the day. Enriched environment C57BL/6J male mice were housed together for 4 days (8-week-old mice) or 1 month (4-week-old mice) in an enrichment cage composed of colored tunnels, mazes, climbing materials, and tilted running wheels (Marlau Cage, ViewPoint Behavior Technology). Controls were age-matched littermates housed in standard conditions.
Morris Water Maze
Testing of 8-12 weeks old C57BL/6J (n = 10) was performed in a 130-cm pool filled with milky water, surrounded by four different objects placed as reference cues onto white curtains. A circular escape platform (10 cm diameter) was submerged 0.5 cm below the water surface. Mice were trained to find the platform during four trials a day, with inter-trial intervals of 5 min spent in their home cage. During training, mice were released from pseudo-randomly assigned start locations; they were allowed to swim for up to 60 s and they were manually guided to the platform in the case of failures. Performance was scored as the average latency to find the platform in the four consecutive trials each day. On the last day, the reference memory was assessed as fraction of time spent in the target quadrant during one full trial (60 s) upon removal of the escape platform. Swim controls (n = 8) were agematched mice that were allowed to swim in the pool without escape platform, in a comparable training regime (four trials per day; inter-trial intervals of 5 min). For swim controls, trial durations for each day were adjusted to average values of training animals. Trials were tracked using EthoVision software (Noldus Information Technology). Rewarded alternation task in T-maze Mice were maintained on a restricted feeding schedule at 85% of their free-feeding weight. Spatial working memory was assessed on a continuous black T-maze consisting of a start arm (60 3 10 cm), two identical goal arms (35 3 10 cm) and two return arms (90 3 10 cm), surrounded by a 14 cm high wall. Light sources in the room were adjusted in order to have the same light intensity in every arm of the maze (20 LUX) and the maze was surrounded by various prominent distal extra-maze cues. The mice were habituated to the maze and to drinking condensed milk pellets over two days for 8 min every day. After habituation, animals were pretrained daily over several days until the consumption of the reward reached minimum 80%. Each pre-training daily session consisted of 4 trials and mice were run one trial at a time with an inter-trial interval (ITI) of approximately 10 min. During the pre-training, one milk pellet was available at the end of the two goal arms as reward and mice were allowed to consume the reward from both arms. For spatial nonmatching-to-place testing, mice were assessed in a counterbalanced order and each trial consisted of a sample run and a choice run. On the sample run, the mice were forced either left or right by the presence of a door, according to a pseudorandom sequence (with equal numbers of left and right turns per session, and with not more than two consecutive turns in the same direction). A reward consisting of one milk pellet was available at the end of the arm. The time interval between the sample run and the choice run was approximately 15 s. The animal was rewarded for choosing the previously unvisited arm (that is, for alternating). Criterion point for a correct trial was that the whole animal (including the tip of the tail) entered the rewarded arm. The maze was cleaned between trials to avoid any potential odor cues. Each daily session consisted of 4 trials and mice were run one trial at a time with an ITI of approximately 10 min.
Open field
The open field consisted of a white PVC enclosed arena (70 3 70 3 30 cm) under uniform lightning conditions (20 LUX). The arena was delimited into two regions using the EthoVision software: an outer zone and an inner zone, a central square area of 35 3 35 cm equidistant from the walls. Mice were placed individually into one corner of the arena facing the sidewalls and were allowed to explore for 10 min. The time spent, velocity, and total distance moved were recorded and video-tracked using EthoVision software. Novel object recognition task The object recognition task took place in the open field apparatus. Mice were individually habituated to the arena for two days. During the training session, two identical objects A1 and A2 were placed into the open field at 20 cm from the walls and the mouse was allowed to explore for 10 min. On the short-term memory (STM) testing trial, after an ITI of 5 min spent in the home cage, the animals were placed back into the open field, where one of the familiar objects was replaced by a novel object B, and allowed to explore freely for 10 min. The position of the novel object (left or right) was randomized between each mouse and each group tested. On the longterm memory (LTM) testing trial (24 hr after the STM testing trial), mice were allowed to explore the open field for 10 min in the presence of two objects: the familiar object A and a second novel object C. The novel object (B or C) was randomized in the STM or LTM sessions between each mouse and each group tested. All objects presented similar textures and sizes, but distinctive shapes and colors. Between trials, the objects were washed with 1% AnistelÒ solution to avoid the use of odor cues. The mice did not show any object preference before trials. Exploratory behavior was videotaped and video-tracked with the EthoVision software and it was measured post hoc using two stopwatches to record the time spent exploring the objects during the experimental sessions. A 20 s criterion of total exploration (or 10 min/session when the criterion was not reached) was used to score exploratory behavior. Object exploration was assessed only if the total time of exploration for each mouse was higher than 5 s in the training session. Exploration was scored whenever the mouse sniffed or touched the object while looking at it (i.e., when the distance between the nose and the object was less than 2 cm). Climbing onto the object (unless the mouse sniffed the object it had climbed on) did not qualify as exploration. To measure recognition memory, a discrimination index (DI) was calculated as the difference in exploration time between the novel and familiar objects, divided by the total time spent exploring both objects [(novel arm -familiar arm) / (novel arm + familiar arm)]. Spatial novelty preference in a Y-maze Spatial novelty preference was assessed as described previously (Sanderson et al., 2009) . Briefly, the spontaneous spatial novelty preference test was conducted using an 8 arm radial maze made from transparent Perspex with arms of 22 3 7 3 20 cm. The maze was placed into a room containing a variety of extra-maze cues. Mice were assigned two arms (''start arm'' and ''familiar arm'') while the entrance to the third arm (the ''novel arm'' during the subsequent test phase) was blocked off with a black door. Allocation of arms (familiar and novel) to specific spatial locations was counterbalanced within each experimental group. During the exposure phase mice were allowed to explore the two arms for 5 min in the one trial exposure test or for 2 min five times, spaced by an ITI of 1 min in the home cage, in the incremental training test. The mouse was then removed from the maze and returned to its home cage for a 1 min interval between the exposure and test phases. During the test phase, mice were placed at the end of the start arm and allowed to explore all three arms for 2 min. An entry into an arm was defined by a mouse placing the forepaws inside an arm. Similarly, a mouse was considered to have left an arm if the forepaws were placed outside the arm. Exploratory behavior was videotaped and videotracked with the EthoVision software and the number of entries and the time that mice spent in each arm were recorded manually. For the test phase, a discrimination index DI = [novel arm -familiar arm] / [novel arm + familiar arm] was calculated for both arm entries and time spent in arms.
Statistical analysis
All statistical analyses were performed using GraphPad Prism 6 (GraphPad Softwares) or SPSS (IBM Corp) softwares. Unless otherwise stated, parametric data were analyzed by t test or one-way ANOVA followed by the Sidak, Holm's or Tukey post hoc analysis for comparisons of multiple samples. Non-parametric data were analyzed by the Mann-Whitney rank sum test or Kruskal-Wallis oneway analysis of variance on ranks followed by the Dunn post hoc analysis for comparisons of multiple samples. Probability distributions were compared using the Kolmogorov-Smirnov test. Statistical details of experiments can be found in the figure legends. p values < 0.05 were considered statistically significant. Data are presented as mean ± SEM.
